Low Seroprevalence among Undetected COVID-19 Cases, Faroe Islands, November 2020

We conducted a second nationwide severe acute respiratory syndrome coronavirus 2 seroprevalence study in the Faroe Islands during November 2020. We found crude seroprevalence was 0.3% and prevalence was 0.4% after adjusting for test sensitivity and specificity. This low seroprevalence supports the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Petersen, Maria Skaalum, Strøm, Marin, Fjallsbak, Jógvan Páll, Hansen, Jóhanna Ljósá, Larsen, Sólrun, Eliasen, Eina H., Johansen, Malan, Veyhe, Anna Sofía, Kristiansen, Marnar Fríðheim, Weihe, Pál
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714219/
https://www.ncbi.nlm.nih.gov/pubmed/34757895
http://dx.doi.org/10.3201/eid2801.210917
Descripción
Sumario:We conducted a second nationwide severe acute respiratory syndrome coronavirus 2 seroprevalence study in the Faroe Islands during November 2020. We found crude seroprevalence was 0.3% and prevalence was 0.4% after adjusting for test sensitivity and specificity. This low seroprevalence supports the prevention strategies used in the Faroe Islands.

Ejemplares similares